← Open Payments lookup

MANISH ZINZUVADIA: Open Payments

NPI 1063726966 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$315,783 in 351 payments from 10 companies in 2025. Trend: 2023 $189,510 · 2024 $238,981 · 2025 $315,783

Speaker / faculty: $226,872Honoraria: $27,225Travel & lodging: $26,895Consulting: $23,449Food & beverage: $11,240Education: $101
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.106$111,826
Teva Pharmaceuticals USA, Inc.53$60,212
Otsuka America Pharmaceutical, Inc.44$56,171
Alkermes, Inc.73$45,998
Axsome Therapeutics, Inc.24$17,134
Luye Pharma (USA) Ltd.15$15,323
ABBVIE INC.20$6,382
Otsuka Pharmaceutical Development & Commercialization, Inc.2$2,053
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$474
Lundbeck LLC10$210

Products named: COBENFY, UZEDY, REXULTI, ABILIFY MAINTENA, ARISTADA, LYBALVI, Auvelity, ERZOFRI EXTENDED-RELEASE.

Industry payments across NY — which companies pay providers there.